Mesenchymal stem cell-based therapy for burn wound healing

Abstract

Burns, with their high incidence and mortality rates, have a devastating effect on patients. There are still huge challenges in the management of burns. Mesenchymal stem cells (MSCs), which have multidirectional differentiation potential, have aroused interest in exploring the capacity for treating different intractable diseases due to their strong proliferation, tissue repair, immune tolerance and paracrine abilities, among other features. Currently, several animal studies have shown that MSCs play various roles and have beneficial effects in promoting wound healing, inhibiting burn inflammation and preventing the formation of pathological scars during burn healing process. The substances MSCs secrete can act on peripheral cells and promote burn repair. According to preclinical research, MSC-based treatments can effectively improve burn wound healing and reduce pain. However, due to the small number of patients and the lack of controls, treatment plans and evaluation criteria vary widely, thus limiting the value of these clinical studies. Therefore, to better evaluate the safety and effectiveness of MSC-based burn treatments, standardization of the application scheme and evaluation criteria of MSC therapy in burn treatment is required in the future. In addition, the combination of MSC pretreatment and dressing materials are also conducive to improving the therapeutic effect of MSCs on burns. In this article, we review current animal research and clinical trials based on the use of stem cell therapy for treating burns and discuss the main challenges and coping strategies facing future clinical applications.

Keywords

Burn / Wound healing / Stem cell-based therapy / Clinical trial / Regenerative medicine / Proliferation / Tissue repair / Inflammation

References

[1] Magne B, Lataillade JJ, Trouillas M. Mesenchymal stromal cell preconditioning: the next step toward a customized treatment for severe burn. Stem Cells Dev. 2018; 27: 1385-405.

[2] Forjuoh SN. Burns in low-and middle-income countries: a review of available literature on descriptive epidemiology, risk factors, treatment, and prevention. Burns. 2006; 32: 529-37.

[3] DeSanti L. Pathophysiology and current Management of Burn Injury CM. Clin Manag. 2012; 25: 38-44.

[4] Ghieh F, Jurjus R, Ibrahim A, Geagea AG, Daouk H, Baba BE, et al. The use of stem cells in burn wound healing: a review. Biomed Res Int. 2015, 684084.

[5] Oryan A, Alemzadeh E, Moshiri A. Burn wound healing: present concepts, treatment strategies and future directions. J Wound Care. 2017; 26: 5-19.

[6] Tuli R, Seghatoleslami MR, Tuli S, Wang ML, Hozack WJ, Manner PA, et al. A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol. 2003; 23: 37-49.

[7] Fujiwara O, Prasai A, Perez-Bello D, El Ayadi A, Petrov IY, Esenaliev RO, et al. Adipose-derived stem cells improve grafted burn wound healing by promoting wound bed blood flow. Burns Trauma. 2020; 8: tkaa009. doi: 10.3109/09553002.2011.570854.

[8] Romanov YA. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells. 2003; 21: 105-10.

[9] Anker PS, Noort WA, Scherjon SA, Kleijburg-Van der Keur C, Kruisselbrink AB, Van Bezooijen RL, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003; 88: 845-52.

[10] Palermo AT, LaBarge MA, Doyonnas R, Pomerantz J, Blau HM. Bone marrow contribution to skeletal muscle: a physiological response to stress. Dev Biol. 2005; 279: 336-44.

[11] Kim K, Blasco-Morente G, Natividad Cuende SA-S. Mesenchymal stromal cells: properties and role in management of cutaneous diseases. J Eur Acad Dermatology Venereol. 2017; 31: 894-7.

[12] Rodgers K, Jadhav SS. The application of mesenchymal stem cells to treat thermal and radiation burns. Adv Drug Deliv. 2018; 123: 75-81.

[13] L PK, Kandoi S, Misra R, Vijayalakshmi S, Cytokine RK.Growth factor reviews the mesenchymal stem cell secretome: a new paradigm towards cell-free therapeutic mode in. Cytokine Growth Factor Rev. 2019; 46: 1-9.

[14] Li X, Liu L, Yang J, Yu Y, Chai J, Wang L, et al. Exosome derived from human umbilical cord Mesenchymal stem cell mediates MiR-181c attenuating burn-induced excessive inflammation. EBioMedicine. 2016; 8: 72-82.

[15] Shpichka A, Butnaru D, Bezrukov EA, Sukhanov RB, Atala A, Vitaliy Burdukovskii YZ, et al. Skin tissue regeneration for burn injury. Stem Cell Res Ther. 2019; 10: 1-16.

[16] Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019; 8: 1605.

[17] Harrell CR, Jankovic MG, Fellabaum C, Volarevic A, Djonov V, Arsenijevic A, et al. Molecular mechanisms responsible for anti-inflammatory and immunosuppressive effects of Mesenchymal stem cell-derived factors. Adv Exp Med Biol. 2019; 1084: 187-206.

[18] Hu P, Yang Q, Wang Q, Shi C, Wang D, Armato U, et al. Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration. Burns Trauma. 2019; 7: 38. doi: 10.1186/s41038-019-0178-8.

[19] Lo Sicco C, Reverberi D, Balbi C, Ulivi V, Principi E, Pascucci L, et al. Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: endorsement of macrophage polarization. Stem Cells Transl Med. 2017; 6: 1018-28.

[20] Regmi S, Pathak S, Kim JO, Yong CS, Jeong JH. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities. and future perspectives. Eur J Cell Biol. 2019; 98(5-8): 151041. doi: 10.1016/j.ejcb.2019.04.002.

[21] Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005; 105: 1815-22.

[22] Batten P, Sarathchandra P, Antoniw JW, Tay SS, Lowdell MW, Taylor PM, et al. Human mesenchymal stem cells induce T cell anergy and downregulate T cell Allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng. 2006; 12: 2263-73.

[23] Yang J, Liu XX, Fan H, Tang Q, Shou ZX, Zuo DM, et al. Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis. PLoS One. 2015; 10:e0140551. doi: 10.1371/journal.pone.0140551.

[24] Yu B, Shao H, Su C, Jiang Y, Chen X, Bai L, et al. Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1. Sci Rep. 2016; 6: 34562. doi: 10.1038/srep34562.

[25] Rowan MP, Cancio LC, Elster EA, Burmeister DM, Rose LF, Natesan S, et al. Burn wound healing and treatment: review and advancements. Crit Care. 2015; 19: 243. doi: 10.1186/s13054-015-0961-2.

[26] Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009; 37: 1528-42.

[27] Gong M, Yu B, Wang J, Wang Y, Liu M, Paul C, et al. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget. 2017; 8: 45200-12.

[28] Ferguson SW, Wang J, Lee CJ, Liu M, Neelamegham S, Canty JM, et al. The microRNA regulatory landscape of MSC-derived exosomes: a systems view. Sci Rep. 2018; 8(1): 1419. doi: 10.1038/s41598-018-19581-x.

[29] Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev. 2015; 24: 1635-47.

[30] Hu L, Wang J, Zhou X, Xiong Z, Zhao J, Yu R, et al. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci Rep. 2016; 6: 32993. doi: 10.1038/srep32993.

[31] Casado-Díaz A, Quesada-Gómez JM, Dorado G. Extracellular vesicles derived from mesenchymal stem cells (MSC) in regenerative medicine: applications in skin wound healing. Front Bioeng Biotechnol. 2020; 8: 146. doi: 10.3389/fbioe.2020.00146.

[32] Ren S, Chen J, Duscher D, Liu Y, Guo G, Kang Y, et al. Microvesicles from human adipose stem cells promote wound healing by optimizing cellular functions via AKT and ERK signaling pathways. Stem Cell Res Ther. 2019; 10(1): 47. doi: 10.1186/s13287-019-1152-x.

[33] Kim S, Lee SK, Kim H, Kim TM. Exosomes secreted from induced pluripotent stem cell-derived mesenchymal stem cells accelerate skin cell proliferation. Int J Mol Sci. 2018; 19(10): 3119. doi: 10.3390/ijms19103119.

[34] Zhang B, Wang M, Gong A, Zhang X, Wu X, Zhu Y, et al. HucMSc-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells. 2015; 33: 2158-68.

[35] Jackson WM, Nesti LJ, Tuan RS. Concise review: clinical translation of wound healing therapies based on Mesenchymal stem cells. Stem Cells Transl Med. 2012; 1: 44-50.

[36] Lee DE, Ayoub N, Agrawal DK. Mesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy. Stem Cell Res Ther. 2016.

[37] Jeon YK, Jang YH, Yoo DR, Kim SN, Lee SK, Nam MJ. Mesenchymal stem cells’ interaction with skin: wound-healing effect on fibroblast cells and skin tissue. Wound Repair Regen. 2010; 18: 655-61.

[38] Wu P, Zhang B, Shi H, Qian H, Xu W. MSC-exosome: a novel cell-free therapy for cutaneous regeneration. Cytotherapy. 2018; 20: 291-301.

[39] Fang S, Xu C, Zhang Y, Xue C, Yang C, Bi H, et al. Umbilical cord-derived mesenchymal stem cell-derived exosomal microRNAs suppress myofibroblast differentiation by inhibiting the transforming growth factor-β/SMAD2 pathway during wound healing. Stem Cells Transl Med. 2016; 5(10): 1425-39. doi: 10.5966/sctm.2015-0367.

[40] Zhang B, Shi Y, Gong A, Pan Z, Shi H, Yang H, et al. HucMSC exosome-delivered 14-3-3ζ orchestrates self-control of the Wnt response via modulation of YAP during cutaneous regeneration. Stem Cells. 2016; 34: 2485-500.

[41] Bensidhoum M, Gobin S, Chapel A, Lemaitre G, Bouet S, Waksman G, et al. Potentiel thérapeutique des cellules souches mésenchymateuses humaines dans les lésions cutanées radioinduites. J Soc Biol. 2005; 199: 337-41.

[42] Mouiseddine M, François S, Semont A, Sache A, Allenet B, Mathieu N, et al. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol. 2007; 80: 49-55.

[43] Hao L, Wang J, Zou Z, Yan G, Dong S, Deng J, et al. Transplantation of BMSCs expressing hPDGF-A/hBD2 promotes wound healing in rats with combined radiation-wound injury. Gene Ther. 2009; 16: 34-42.

[44] Yan G, Sun H, Wang F, Wang J, Wang F, Zou Z, et al. Topical application of hPDGF-A-modified porcine BMSC and keratinocytes loaded on acellular HAM promotes the healing of combined radiation-wound skin injury in minipigs. Int J Radiat Biol. 2011; 87: 591-600.

[45] Agay D, Scherthan H, Forcheron F, Grenier N, Hérodin F, Meineke V, et al. Multipotent mesenchymal stem cell grafting to treat cutaneous radiation syndrome: development of a new minipig model. Exp Hematol. 2010; 38: 945-56.

[46] Forcheron F, Agay D, Scherthan H, Riccobono D, Herodin F, Meineke V, et al. Autologous adipocyte derived stem cells favour healing in a minipig model of cutaneous radiation syndrome. PLoS One. 2012; 7(2): e31694. doi: 10.1371/journal.pone.0031694.

[47] Horton JA, Hudak KE, Chung EJ, White AO, Scroggins BT, Burkeen JF, et al. Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation. Stem Cells. 2013; 31: 2231-41.

[48] Zhang X, Guo R, Xu J, Lan Y, Jiao Y, Zhou C, et al. Poly(l-lactide)/halloysite nanotube electrospun mats as dual-drug delivery systems and their therapeutic efficacy in infected full-thickness burns. J Biomater Appl. 2015; 30: 512-25.

[49] Zou Q, Hong W, Zhou Y, Ding Q, Wang J, Jin W, et al. Bone marrow stem cell dysfunction in radiation-induced abscopal bone loss. J Orthop Surg Res. 2016; 11: 3. doi: 10.1186/s13018-015-0339-9.

[50] Zeng W, Li Y, Zeng G, Yang B, Zhu Y. Transplantation with cultured stem cells derived from the human amniotic membrane for corneal alkali burns: an experimental study. Ann Clin Lab Sci. 2014; 44: 73-81.

[51] Ke Y, Wu Y, Cui X, Liu X, Yu M, Yang C, et al. Polysaccharide hydrogel combined with mesenchymal stem cells promotes the healing of corneal alkali burn in rats. PLoS One. 2015; 10(3): e0119725. doi: 10.1371/journal.pone.0119725.

[52] Cejka C, Holan V, Trosan P, Zajicova A, Javorkova E, Cejkova J. The Favorable effect of Mesenchymal stem cell treatment on the antioxidant protective mechanism in the corneal epithelium and renewal of corneal optical properties changed after alkali burns. Oxid Med Cell Longev. 2016; 5843809. doi: 10.1155/2016/5843809.

[53] Ebrahim N, Mohammed OM, Dessouky AA, Fatah DSA. The potential therapeutic effect of stem cells loaded on two different vehicles (amniotic membrane and platelet rich plasma gel) in experimentally induced corneal alkali burns in rats. Egypt J Histol. 2017; 40: 405-26.

[54] Dai Y, Li J, Li J, Dai G, Mu H, Wu Q, et al. Skin epithelial cells in mice from umbilical cord blood mesenchymal stem cells. Burns. 2007; 33: 418-28.

[55] Ha XQ, De LT, Hui L, Dong F. Effects of mesenchymal stem cells transfected with human hepatocyte growth factor gene on healing of burn wounds. Chin J Traumatol. 2010; 13: 349-55.

[56] Oryan A, Alemzadeh E, Mohammadi AA. Application of honey as a protective material in maintaining the viability of adipose stem cells in burn wound healing: a histological, molecular and biochemical study. Tissue Cell. 2019; 61: 89-97.

[57] Mahmood R, Mehmood A, Choudhery MS, Awan SJ, Khan SN, Riazuddin S. Human neonatal stem cell-derived skin substitute improves healing of severe burn wounds in a rat model. Cell Biol Int. 2019; 43: 147-57.

[58] Franck CL, Senegaglia AC, Leite LMB, De Moura SAB, Francisco NF, Ribas Filho JM. Influence of adipose tissue-derived stem cells on the burn wound healing process. Stem Cells Int. 2019; 2340725. doi: 10.1155/2019/2340725.

[59] Babakhani A, Nobakht M, Torodi HP, Dahmardehei M, Hashemi P, Ansari JM, et al. Effects of hair follicle stem cells on partial-thickness burn wound healing and tensile strength. Iran Biomed J. 2020; 24: 99-109.

[60] Lü MH, Hu CJ, Chen L, Peng X, Chen J, Hu JY, et al. miR-27b represses migration of mouse MSCs to burned margins and prolongs wound repair through silencing SDF-1a. PLoS One. 2013; 8(7): e68972. doi: 10.1371/journal.pone.0068972.

[61] Jiang D, Qi Y, Walker NG, Sindrilaru A, Hainzl A, Wlaschek M, et al. The effect of adipose tissue derived MSCs delivered by a chemically defined carrier on full-thickness cutaneous wound healing. Biomaterials. 2013; 34: 2501-15.

[62] Dai J, Tan Q, Yan X, Yang Y, Wang H, Shen L, et al. Acceleration of wound healing in acute full-thickness skin wounds using a collagen-binding peptide with an affinity for MSCs. Burns Trauma. 2014; 2(4): 181-6. doi: 10.4103/2321-3868.143623.

[63] Steffens D, Leonardi D, Da Luz Soster PR, Lersch M, Rosa A, Crestani T, et al. Development of a new nanofiber scaffold for use with stem cells in a third degree burn animal model. Burns. 2014; 40: 1650-60.

[64] Zhang J, La X, Fan L, Li P, Yu Y, Huang Y, et al. Immunosuppressive effects of mesenchymal stem cell transplantation in rat burn models. Int J Clin Exp Pathol. 2015; 8: 5129-36.

[65] Chen YW, Scutaru TT, Ghetu N, Carasevici E, Lupascu CD, Ferariu D, et al. The effects of adipose-derived stem cell-differentiated adipocytes on skin burn wound healing in rats. J Burn Care Res. 2017; 38(1): 181-6. doi: 10.1097/BCR.0000000000000466.

[66] Oh EJ, Lee HW, Kalimuthu S, Kim TJ, Kim HM, Baek SH, et al. In vivo migration of mesenchymal stem cells to burn injury sites and their therapeutic effects in a living mouse model. J Control Release. 2018; 279: 79-88.

[67] Zhou X, Ning K, Ling B, Chen X, Cheng H, Lu B, et al. Multiple injections of autologous adipose-derived stem cells accelerate the burn wound healing process and promote blood vessel regeneration in a rat model. Stem Cells Dev. 2019; 28: 1463-72.

[68] Shumakov VI, Onishchenko NA, Rasulov MF, Krasheninnikov ME, Zaidenov VA. Mesenchymal bone marrow stem cells more effectively stimulate regeneration of deep burn wounds than embryonic fibroblasts. Bull Exp Biol Med. 2003; 136(2): 192-5. doi: 10.1023/a:1026387411627.

[69] Fujii H, Tomita S, Nakatani T, Fukuhara S, Hanatani A, Ohtsu Y, et al. A novel application of myocardial contrast echocardiography to evaluate angiogenesis by autologous bone marrow cell transplantation in chronic ischemic pig model. J Am Coll Cardiol. 2004; 43: 1299-305.

[70] Cuttle L, Kempf M, Kravchuk O, George N, Liu PY, Chang HE, et al. The efficacy of Aloe vera, tea tree oil and saliva as first aid treatment for partial thickness burn injuries. Burns. 2008; 34: 1176-82.

[71] Hu C, Yong X, Li C, Lü M, Liu D, Chen L, et al. CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair. J Surg Res. 2013; 183: 427-34.

[72] Öksüz S, Ülkür E, Öncül O, Köse GT, Küçükodac Z, Urhan M. The effect of subcutaneous mesenchymal stem cell injection on statis zone and apoptosis in an experimental burn model. Plast Reconstr Surg. 2013; 131: 463-71.

[73] Liu L, Yu Y, Hou Y, Chai J, Duan H, Chu W, et al. Human umbilical cord mesenchymal stem cells transplantation promotes cutaneous wound healing of severe burned rats. PLoS One. 2014; 9(2): e88348. doi: 10.1371/journal.pone.0088348.

[74] Clover AJP, Kumar AHS, Isakson M, Whelan D, Stocca A, Gleeson BM, et al. Allogeneic mesenchymal stem cells, but not culture modified monocytes, improve burn wound healing. Burns. 2015; 41: 548-57.

[75] Caliari-Oliveira C, Yaochite JNU, Ramalho LNZ, Palma PVB, Carlos D, Cunha F d Q, et al. Xenogeneic mesenchymal stromal cells improve wound healing and modulate the immune response in an extensive burn model. Cell Transplant. 2016; 25: 201-15.

[76] Guo X, Xia B, Lu XB, Zhang ZJ, Li Z, Li WL, et al. Grafting of mesenchymal stem cell-seeded small intestinal submucosa to repair the deep partial-thickness burns. Connect Tissue Res. 2016; 57: 388-97.

[77] Alapure BV, Lu Y, He M, Chu CC, Peng H, Muhale F, et al. Accelerate healing of severe burn wounds by mouse bone marrow mesenchymal stem cell-seeded biodegradable hydrogel scaffold synthesized from arginine-based poly(ester amide) and chitosan. Stem Cells Dev. 2018; 27: 1605-20.

[78] Xue L, Bin XY, Xie JL, Tang JM, Shu B, Chen L, et al. Effects of human bone marrow mesenchymal stem cells on burn injury healing in a mouse model. Int J Clin Exp Pathol. 2013; 6: 1327-36.

[79] Karimi H, Soudmand A, Orouji Z, Taghiabadi E, Mousavi SJ. Burn wound healing with injection of adipose-derived stem cells: a mouse model study. Ann Burns Fire Disasters. 2014; 27: 44-9.

[80] Xia Z, Zhang C, Zeng Y, Wang T, Ai G. Transplantation of BMSCs expressing hVEGF165/hBD3 promotes wound healing in rats with combined radiation-wound injury. Int Wound J. 2014; 11: 293-303.

[81] Xu Y, Huang S, Fu X. Autologous transplantation of bone marrow-derived mesenchymal stem cells: a promising therapeutic strategy for prevention of skin-graft contraction. Clin Exp Dermatol. 2012; 37: 497-500.

[82] Mansilla E, Marín GH, Berges M, Scafatti S, Rivas J, Núñez A, et al. Cadaveric bone marrow mesenchymal stem cells: first experience treating a patient with large severe burns. Burns Trauma. 2015; 3: 17. doi: 10.1186/s41038-015-0018-4.

[83] Rasulov MF, Vasil AV, Onishchenko NA, Krasheninnikov ME, Kravchenko VI, Gorshenin TL, et al. First experience in the use of bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns. Bull Exp Biol Med. 2005; 139(1): 141-4. doi: 10.1007/s10517-005-0232-3.

[84] Yoshikawa T, Mitsuno H, Nonaka I, Sen Y, Kawanishi K, Inada Y, et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg. 2008; 121: 860-77.

[85] Maranda EL, Wang MX, Shareef S, Tompkins BA, Emerson C, Badiavas EV. Surgical management of leukoderma after burn: a review. Burns. 2018; 44: 256-62.

[86] Gal S, Ramirez JI, Maguina P. Autologous fat grafting does not improve burn scar appearance: a prospective, randomized, double-blinded, placebo-controlled, pilot study. Burns. 2017; 43: 486-9.

[87] Nielson CB, Duethman NC, Howard JM, Moncure M, Wood JG. Burns: pathophysiology of systemic complications and current management. J Burn Care Res. 2017 Jan/Feb; 38(1): e469-e481. doi: 10.1097/BCR.0000000000000355.

[88] Williams FN, Herndon DN. Metabolic and endocrine considerations after burn injury. Clin Plast Surg. 2017; 44: 541-53.

[89] Porter C, Herndon DN, Sidossis LS, Børsheim E. The impact of severe burns on skeletal muscle mitochondrial function. Burns. 2013; 39: 1039-47.

[90] Abo-Elkheir W, Hamza F, Elmofty AM, Emam A, Abd-Moktader M, Elsherefy S, et al. Role of cord blood and bone marrow mesenchymal stem cells in recent deep burn: a case-control prospective study. Am J Stem Cells. 2017; 6: 23-35.

[91] Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011; 9: 11-5.

[92] Hu P, Yang Q, Wang Q, Shi C, Wang D, Armato U, et al. Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration. Burns Trauma. 2019; 7: 38. doi: 10.1186/s41038-019-0178-8.

[93] Kucharzewski M, Rojczyk E, Wilemska-Kucharzewska K, Wilk R, Hudecki J, Los MJ. Novel trends in application of stem cells in skin wound healing. Eur J Pharmacol. 2019; 843: 307-15.

[94] da Silva Meirelles L, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009; 20: 419-27.

[95] Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol. 2016; 1416: 123-46. doi: 10.1007/978-1-4939-3584-0_7.

[96] Börger V, Bremer M, Ferrer-Tur R, Gockeln L, Stambouli O, Becic A, et al. Mesenchymal stem/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents. Int J Mol Sci. 2017; 18(7): 1450. doi: 10.3390/ijms18071450.

[97] Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011; 9: 12. doi: 10.1186/1478-811X-9-12.

[98] Lv F, Lu M, Cheung KM, Leung VY, Zhou G. Intrinsic properties of mesemchymal stem cells from human bone marrow, umbilical cord and umbilical cord blood comparing the different sources of MSC. Curr Stem Cell Res Ther. 2012; 7(6): 389-99. doi: 10.2174/157488812804484611.

[99] Wang Y, Han ZB, Song YP, Han ZC. Safety of mesenchymal stem cells for clinical application. Stem Cells Int. 2012; 652034. doi: 10.1155/2012/652034.

[100] Kang SK, Shin IS, Ko MS, Jo JY, Ra JC. Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. > Stem Cells Int. 2012; 342968. doi: 10.1155/2012/342968.

[101] Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017; 18(9): 1852. doi: 10.3390/ijms18091852.

[102] Ahmadi AR, Chicco M, Huang J, Qi L, Burdick J, Williams GM, et al. Stem cells in burn wound healing: a systematic review of the literature. Burns. 2019; 45(5): 1014-23. doi: 10.1016/j.burns.

[103] García-Sánchez D, Fernández D, Rodríguez-Rey JC, Pérez-Campo FM. Enhancing survival, engraftment, and osteogenic potential of mesenchymal stem cells. World J Stem Cells. 2019; 11(10): 748-63. doi: 10.4252/wjsc.v11.i10.748.

[104] Bunpetch V, Zhang ZY, Zhang X, Han S, Zongyou P, Wu H, et al. Strategies for MSC expansion and MSC-based microtissue for bone regeneration. Biomaterials. 2019; 196: 67-79. doi: 10.1016/j.biomaterials.2017.11.023.

[105] Cossu G, Birchall M, Brown T, De Coppi P, Culme-Seymour E, Gibbon S, et al. Lancet commission: stem cells and regenerative medicine. Lancet. 2018; 391: 883-910.

[106] Xu PC, Xuan M, Cheng B. Effects and mechanism of platelet-rich plasma on military drill injury: a review. Mil. Med. Res. BioMed Central Ltd. 2020; 7(1): 56. doi: 10.1186/s40779-020-00285-1.

[107] Phan J, Kumar P, Hao D, Kewa Gao DF. Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy. J Extracell Vesicles. 2018; 7(1): 1522236. doi: 10.1080/20013078.2018.1522236.

[108] Ketterl N, Brachtl G, Schuh C, Bieback K, Schallmoser K, Reinisch A, et al. A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance. Stem Cell Res Ther. 2015; 6: 236. doi: 10.1186/s13287-015-0233-8.

[109] Mansilla E, Marín GH, Berges M, Scafatti S, Rivas J, Núñez A, et al. Cadaveric bone marrow mesenchymal stem cells: first experience treating a patient with large severe burns. Burns Trauma. 20153: 17. doi: 10.1186/s41038-015-0018-4.

[110] Xu Y, Huang S, Fu X. Autologous transplantation of bone marrow-derived mesenchymal stem cells: a promising therapeutic strategy for prevention of skin-graft contraction. Clin Exp Dermatol. 2012; 37: 497-500.

[111] Yoshikawa T, Mitsuno H, Nonaka I, Sen Y, Kawanishi K, Inada Y, et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg. 2008; 121: 860-77.

[112] Rasulov MF, Vasil’chenkov A V., Onishchenko NA, Krasheninnikov ME, Kravchenko VI, Gorshenin TL, et al. First experience of the use bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns. Bull Exp Biol Med. 2005; 139: 141-4.

[113] Elsherefy S, Gabr H. Role of cord blood and bone marrow mesenchymal stem cells in recent deep burn: a case-control prospective study. Am J Stem Cells. 2017; 6(3): 23-35.